GlassScriptPhysician profile
Jason Andrew Brown
NPI 1619316775
$10,232.30
in general payments reported to CMS, 2019-2025
22 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $152 · 2021: $71.03 · 2022: $125 · 2023: $256 · 2024: $9,504 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Travel and Lodging: $3,531 · Food and Beverage: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Travel and Lodging | $3,531.14 |
| Food and Beverage | $852.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,142.42 | 2024 | |
| Davol INC. | $1,478.97 | 2021-2025 | Phasix Mesh |
| Portola Pharmaceuticals, LLC | $125.00 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $76.64 | 2023 | Rexulti, Abilify Maintena |
| Chiesi USA, INC. | $62.05 | 2022 | |
| Ethicon US, LLC | $32.29 | 2023 | Enseal |
| Allergan, INC. | $29.32 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $27.34 | 2020 | |
| Abbott Laboratories | $25.85 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Kci USA, INC. | $24.78 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $24.59 | 2025 | Caplyta |
| Edwards Lifesciences Corporation | $23.96 | 2024 | |
| Glaxosmithkline, LLC. | $19.58 | 2023 | Trelegy Ellipta, Shingrix |
| Lundbeck LLC | $19.41 | 2025 | Vyepti |
| Amgen INC. | $16.93 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.80 | 2025 | Jardiance |
| Corcept Therapeutics | $15.20 | 2025 | Korlym |
| Hologic Sales and Service, LLC | $15.08 | 2025 | Aptima, Thinprep 2000 Processor |
| Halozyme INC | $14.83 | 2023 | |
| Novo Nordisk INC | $14.48 | 2024 | Ozempic, Rybelsus |
| Integra Lifesciences Corporation | $14.16 | 2021 | |
| Medtronic, INC. | $13.62 | 2023 | Ligasure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.